Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
SUSPENDED
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation
Sponsor: Centre for Infectious Disease Research in Zambia
View on ClinicalTrials.gov
Summary
The primary purpose of this study is to assess the burden of advanced HIV disease (CD4 cell count \<200 or \<350 cells/μL) among new patients and those returning to care after a gap in treatment, and the extent to which low coverage of CD4 cell count measurement among these patients may prevent adequate management of those with advanced HIV disease.
Official title: CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation (CAIR)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
151
Start Date
2024-11-28
Completion Date
2028-03
Last Updated
2026-08-12
Healthy Volunteers
No
Conditions
Locations (1)
Chawama
Lusaka, Lusaka Province, Zambia